Watch this DDW listicle exploring how biomarkers are reducing risk in drug discovery and clinical trials, sponsored by Olink. As drug development becomes increasingly complex, smarter decisions depend on having the right biological data at the right time. In this video, hosted by Drug Discovery World (DDW) and sponsored by Olink, we highlight how protein biomarker insights are helping researchers improve target selection and make more informed decisions across the R&D pipeline.

You will learn:

• How multiomics integration connects genotype to phenotype
• Why reverse translation strengthens early drug discovery
• How to maximise the value of limited biological samples
• How biomarkers enable early efficacy evaluation in the clinic
• Why patient segmentation and non-invasive endpoints improve trial design

Watch now to discover how biomarker-driven strategies can move drug development from insight to impact.